- Medical School - Aga Khan Medical College, Pakistan (2009-2014)
- Fellowship - UT Southwestern Medical Center (2020-2023), Hematology Oncology
- Residency - Temple University Hospital (2017-2020), Internal Medicine
Mohammad (Faizan) Zahid, M.D.
- Internal Medicine - Hematology/Oncology
- Hematologic Malignancies
- Acute Leukemia
Biography
Mohammad "Faizan" Zahid, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center. He specializes in malignant hematology, leukemia, lymphoma, multiple myeloma and other plasma cell disorders, and novel treatment strategies for patients who can’t receive stem cell transplantation.
Dr. Zahid earned his medical degree at the Aga Khan University Medical College in Pakistan. He completed his residency in internal medicine at Temple University Hospital in Philadelphia and then received advanced training in hematology and medical oncology through a fellowship at UT Southwestern Medical Center, where he served as Chief Fellow.
Certified by the American Board of Internal Medicine in hematology and oncology, he joined the UT Southwestern faculty in 2023.
Dr. Zahid is involved in ongoing research projects and has published numerous academic articles related to his areas of expertise.
He is a member of the American Society of Hematology, the American Society of Clinical Oncology, and the Society of Hematologic Oncology. He serves as a reviewer for BMJ Case Reports.
In 2023, he earned UT Southwestern’s Undergraduate Medical Education Outstanding Fellow Teaching Award.
Personal Note
When he’s not at work, Dr. Zahid enjoys taking photographs, painting, cooking, and bird-watching.
Education & Training
Professional Associations & Affiliations
- American Society of Clinical Oncology
- American Society of Hematology
- Society of Hematologic Oncology
Honors & Awards
- Undergraduate Medical Education Outstanding Fellow Teaching Award 2023, UT Southwestern Medical Center
- Chief Fellow 2022-2023, UT Southwestern Hematology/Oncology Fellowship Program
- Academic Excellence in American Society of Hematology In-Service Exam 2022, UT Southwestern Medical Center
- Sol Sherry Award for Excellence in Research by a Resident 2019, Lewis Katz School of Medicine at Temple University
- Resident Research Career Development Award 2018, Lewis Katz School of Medicine at Temple University
Books & Publications
-
Publications
-
Sustained long-term remission with tyrosine kinase inhibitor therapy in treatment-refractory B-cell acute lymphoblastic leukemia harboring a RCSD1::ABL2 fusion gene.
Zahid MF, Kainthla R, Leukemia & lymphoma 2023 Oct 1-5 -
Identifying patients at risk for hereditary myeloid malignancy syndromes incorporating a novel, self-administered questionnaire to an initial screening platform.
Zahid MF, Moriarty K, Dryden C, Weinberg O, Asif M, Ikpefan R, Anderson JM, Collins RH, Chung SS, Chen W, Patel PA, Madanat YF, European journal of haematology 2023 Aug -
Dinner-plate nuclei in hypogranular acute promyelocytic leukemia.
Zahid MF, Kainthla R, Blood 2022 Dec 140 23 2519 -
Physician-scientist or basic scientist? Exploring the nature of clinicians' research engagement.
Cianciolo AT, Mitzelfelt J, Ghareeb A, Zahid MF, Akbar R, Ghias K, Advances in health sciences education : theory and practice 2021 May 26 2 353-367 -
Cannon ball pulmonary metastases in renal cell carcinoma.
Zahid MF, Bowman IA, QJM : monthly journal of the Association of Physicians 2021 Apr 114 2 132-133 -
Can we prevent or treat graft-versus-host disease with cellular-therapy?
Zahid MF, Lazarus HM, Ringdén O, Barrett JA, Gale RP, Hashmi SK, Blood reviews 2020 Sep 43 100669 -
Sorafenib-induced tumor lysis syndrome in a patient with metastatic hepatocellular carcinoma.
Imam SZ, Zahid MF, Maqbool MA, Hematology/oncology and stem cell therapy 2020 Sep 13 3 168-170 -
Infections in patients with multiple myeloma treated with conventional chemotherapy: a single-center, 10-year experience in Pakistan.
Zahid MF, Ali N, Nasir M, Baig MH, Iftikhar M, Bin Mahmood SU, Malik A, Atif S, Beg MA, Hematology, transfusion and cell therapy 2019 41 4 292-297 -
Outcome of hairy cell leukemia patients treated with cladribine - a 10-year single-center experience in Pakistan.
Zahid MF, Mehdi MQ, Ali N, Hematology, transfusion and cell therapy 2019 41 2 134-138 -
Rapid resolution of prostate cancer-related hemolytic uremic syndrome without plasma exchange - a case report.
Imam SZ, Zahid MF, Maqbool MA, Hematology, transfusion and cell therapy 2019 41 3 275-277 -
Spurious Thrombocytosis in the Setting of Hemolytic Anemia and Microcytosis Secondary to Extensive Burn Injury.
Zahid MF, Alsammak MS, Turkish journal of haematology : official journal of Turkish Society of Haematology 2018 Aug 35 3 205-206 -
Rapidly fatal Klebsiella pneumoniae sepsis in a patient with pyruvate kinase deficiency and asplenia.
Zahid MF, Bains APS, Blood 2017 Dec 130 26 2906 -
Cytogenetic Abnormalities in Myelodysplastic Syndromes: An Overview.
Zahid MF, Malik UA, Sohail M, Hassan IN, Ali S, Shaukat MHS, International journal of hematology-oncology and stem cell research 2017 Jul 11 3 231-239 -
Spectrum of autoimmune diseases and systemic inflammatory syndromes in patients with chronic myelomonocytic leukemia.
Zahid MF, Barraco D, Lasho TL, Finke C, Ketterling RP, Gangat N, Hanson CA, Tefferi A, Patnaik MM, Leukemia & lymphoma 2017 Jun 58 6 1488-1493 -
Insight into the molecular pathophysiology of myelodysplastic syndromes: targets for novel therapy.
Zahid MF, Patnaik MM, Gangat N, Hashmi SK, Rizzieri DA, European journal of haematology 2016 Oct 97 4 313-20 -
Venous thromboembolism following hematopoietic stem cell transplantation-a systematic review and meta-analysis.
Zahid MF, Murad MH, Litzow MR, Hogan WJ, Patnaik MS, Khorana A, Spyropoulos AC, Hashmi SK, Annals of hematology 2016 Sep 95 9 1457-64 -
Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevance.
Patnaik MM, Zahid MF, Lasho TL, Finke C, Ketterling RL, Gangat N, Robertson KD, Hanson CA, Tefferi A, Blood cancer journal 2016 Sep 6 9 e472 -
Therapy-related myeloid neoplasms - what have we learned so far?
Zahid MF, Parnes A, Savani BN, Litzow MR, Hashmi SK, World journal of stem cells 2016 Aug 8 8 231-42 -
The role of bortezomib in the treatment of acute lymphoblastic leukemia.
Zahid MF, Future oncology (London, England) 2016 Aug 12 16 1861-4 -
Central nervous system prophylaxis in diffuse large B-cell lymphoma.
Zahid MF, Khan N, Hashmi SK, Kizilbash SH, Barta SK, European journal of haematology 2016 Aug 97 2 108-20 -
Can We Cure Light Chain Deposition Disease of the Kidneys?-A Review and Case Report of a Patient Treated With a Triple Transplant Approach.
Sivaraj D, Green MM, Ciftci AM, Zahid MF, Johns AA, Ross M, Gasparetto C, Clinical lymphoma, myeloma & leukemia 2016 Jun 16 6 e95-e100 -
Treating the Hodgkin's Lymphoma Variant of Richter's Transformation.
Zahid MF, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2016 Apr 26 4 344-5 -
Genomic imbalances in peripheral blood confirm the diagnosis of myelodysplastic syndrome in a patient presenting with non-immune hemolytic anemia.
Zahid MF, Khan N, Pei J, Testa JR, Dulaimi E, Leukemia research reports 2016 5 23-6 -
Haploidentical Hematopoietic Stem Cell Transplantation: Expanding the Horizon for Hematologic Disorders.
Zahid MF, Rizzieri DA, Advances in hematology 2016 2016 1423493 -
Methods of reducing pain during bone marrow biopsy: a narrative review.
Zahid MF, Annals of palliative medicine 2015 Oct 4 4 184-93 -
Reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation for chronic lymphocytic leukemia.
Zahid MF, Ali N, Medical oncology (Northwood, London, England) 2015 Jul 32 7 186 -
5-Fluorouracil-induced vasculitic injury manifesting as a multiorgan dysfunction in a patient with esophageal carcinoma.
Zahid MF, Masood N, Shabbir-Moosajee M, Journal of cancer research and therapeutics 2015 11 3 653 -
Mammary myofibroblastoma: a clinico- pathologic study of six cases.
Zahid MF, Zafar I, Din NU, Ahmed A, Fatima S, Kayani N, Breast disease 2015 35 2 143-8 -
Outcome of allogeneic hematopoietic stem cell transplantation in patients with hematological malignancies.
Zahid MF, Ali N, Shaikh MU, Adil SN, International journal of hematology-oncology and stem cell research 2014 Oct 8 4 30-8
-
Sustained long-term remission with tyrosine kinase inhibitor therapy in treatment-refractory B-cell acute lymphoblastic leukemia harboring a RCSD1::ABL2 fusion gene.
Research
- Hematologic malignancies
- Novel combination strategies and maintenance regimens for patients unable to receive stem cell transplantation
- Real-world outcomes
- Health care disparities
Clinical Focus
- Hematologic Malignancies
- Acute Leukemia
- Aggressive Lymphoma
- Multiple Myeloma/Plasma Cell Disorders